
Dyjest is the must-have tracking app for all patients with digestive disorders, especially Irritable Bowel Syndrom. Powered by artificial intelligence algorithms, Dyjest allows patients to better understand how their behaviors affect their well-being, and to personalize their diet in order to regain a real life comfort. IBS is a chronic gastrointestinal disease that affects more than 10% of the world's population. Faced with a lack of effective medical solutions, Dyjest intends to give hope to patients through personalized care. Based on a strong technological foundation, and supported by healthcare professionals specialized in digestive disorders (gastroenterologists and dietitians), Dyjest aims to become the perfect assistant of all IBS patients. Work in progress ✨

Dyjest is the must-have tracking app for all patients with digestive disorders, especially Irritable Bowel Syndrom. Powered by artificial intelligence algorithms, Dyjest allows patients to better understand how their behaviors affect their well-being, and to personalize their diet in order to regain a real life comfort. IBS is a chronic gastrointestinal disease that affects more than 10% of the world's population. Faced with a lack of effective medical solutions, Dyjest intends to give hope to patients through personalized care. Based on a strong technological foundation, and supported by healthcare professionals specialized in digestive disorders (gastroenterologists and dietitians), Dyjest aims to become the perfect assistant of all IBS patients. Work in progress ✨
Product: Tracking app for patients with digestive disorders (focus on IBS) using AI to personalize diet
Market: Patients with Irritable Bowel Syndrome (chronic gastrointestinal disease)
Support: Supported by gastroenterologists and dietitians
Funding signal: Received non-equity assistance from Eurasanté (Mar 23, 2022)
Chronic gastrointestinal disorders, primarily Irritable Bowel Syndrome (IBS).
Digital health / Healthtech
Recorded as non-equity assistance (amount undisclosed)